Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
about
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityCardiovascular risk in rheumatoid arthritis: assessment, management and next stepsMetabolic syndrome in rheumatoid arthritisMetabolic syndrome in rheumatoid arthritis: case control studyCardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentPrevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors.Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa!Prevalence and concomitants of arthritis in the elderly in Rio Grande do Sul, Brazil.Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular diseaseIncreased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis.The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies.Comorbidity in inflammatory bowel disease.Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS andMeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set AnalysisThe relationship of metabolic syndrome with disease activity and the functional status in patients with rheumatoid arthritisMetabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis.Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritisRelationship between Metabolic Syndrome and Rheumatoid ArthritisIs the frequency of metabolic syndrome higher in South Korean women with rheumatoid arthritis than in healthy subjects?Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome.Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease.Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.Methotrexate promotes glucose uptake and lipid oxidation in skeletal muscle via AMPK activation.Methotrexate enhances 3T3-L1 adipocytes hypertrophy.Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis.Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.Energy expenditure and nutritional complications of metabolic syndrome and rheumatoid cachexia in rheumatoid arthritis: an observational study using calorimetry and actimetry.Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report.The role of methotrexate and low-dose prednisolone on adiponectine levels and insulin resistance in patients with rheumatoid arthritis naïve to disease-modifying antirheumatic drugs.Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters
P2860
Q24630655-243E9977-77B6-4AA3-8A9E-030532342F05Q26744334-52C7D813-48E8-4A6D-A451-4D776E3FA1B0Q26822038-51408D73-90CE-4322-A4FA-6A2B6309DEB2Q31116097-EA8541B1-0517-47C9-AC7B-3BB97A5A8D13Q33943374-90B9EEBD-7A31-4539-B5B3-15612F7F4376Q34167222-DA61C9AA-D581-4CC1-B377-2A9E4460FBBEQ34167653-7AB04C53-D1CD-4C1A-AA40-1FA0CD1D800BQ34428989-64349F7A-8AA6-4AB0-81C2-2943DDF6FE4AQ34459100-72F1AA78-117D-49E5-8BB9-5902D8879419Q34614038-C7327F54-E271-4687-9A0C-DF88EADA80E4Q34681057-83C54148-46B3-4811-AEEB-0D1D2D8BB38BQ35036116-4CDADE89-0B2B-42CF-BFE1-E72543A44ABDQ35065318-CC9126B7-6E27-4570-85E8-80869737CC42Q35185494-E36DD708-4D74-49D5-AE4F-51B0B0E91765Q35615158-B06DE5E4-9841-478E-8E64-419A6E752E4CQ36132235-7EC8AA1B-1C60-471D-94C7-4530CD6856D6Q36319729-F2AE3EE0-DF06-4B57-B9C9-F76B7F0462AFQ36456346-04E76FA1-43A2-4586-9D71-B9D6AF7A3D34Q36582149-1EE31534-478C-463B-883A-30CEFFB496D2Q36705720-F0B80A2A-EE63-46EE-BFD1-C79ECC3C6483Q37454091-F889AD70-2588-4537-B733-71AB55EBE99DQ37859679-B544DAE4-D669-4509-868E-7DA6EFD7C215Q38858035-3388C01F-B780-4B41-9F9D-61AB9B1839F1Q38945736-24AE1706-815C-4BA3-9D57-D2182D0EF70BQ39108736-2877C8FC-5E66-4CB7-A1F3-E3437122451FQ39882466-350BF06D-2D3E-46BB-B916-FDE7876B6B53Q40149467-69595A1A-D40E-4258-8378-0699B690C73BQ48508157-770FDF90-8AA4-4853-B15B-A06A653F1346Q48840645-3227F983-9729-4995-9579-D7AEB147D536Q50957777-3EFE2657-3E85-4991-A4F8-F31C6D0A1E6FQ51243846-BF8AD67F-98BB-4F50-9635-05AB7B88AA72Q51299339-05EC6980-CA43-4330-B725-720B27B69678Q58134529-DB5DC406-5D57-4AFE-8E57-1ED9DB817EC3
P2860
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Methotrexate therapy associate ...... fect? A cross sectional study.
@en
Methotrexate therapy associate ...... fect? A cross sectional study.
@nl
type
label
Methotrexate therapy associate ...... fect? A cross sectional study.
@en
Methotrexate therapy associate ...... fect? A cross sectional study.
@nl
prefLabel
Methotrexate therapy associate ...... fect? A cross sectional study.
@en
Methotrexate therapy associate ...... fect? A cross sectional study.
@nl
P2093
P2860
P921
P356
P1476
Methotrexate therapy associate ...... fect? A cross sectional study.
@en
P2093
George D Kitas
Holly John
Karen M J Douglas
Tracey E Toms
Vasileios F Panoulas
P2860
P2888
P356
10.1186/AR2765
P577
2009-07-16T00:00:00Z
P5875
P6179
1025410621